» Articles » PMID: 35282391

Enhancing Fracture Repair: Cell-based Approaches

Overview
Journal OTA Int
Date 2022 Mar 14
PMID 35282391
Authors
Affiliations
Soon will be listed here.
Abstract

Fracture repair is based both on the macrolevel modulation of fracture fragments and the subsequent cellular activity. Surgeons have also long recognized other influences on cellular behavior: the effect of the fracture or subsequent surgery on the available pool of cells present locally in the periosteum, the interrelated effects of fragment displacement, and construct stiffness on healing potential, patient pathophysiology and systemic disease conditions (such as diabetes), and external regulators of the skeletal repair (such as smoking or effect of medications). A wide variety of approaches have been applied to enhancing fracture repair by manipulation of cellular biology. Many of these approaches reflect our growing understanding of the cellular physiology that underlies skeletal regeneration. This review focuses on approaches to manipulating cell lineages, influencing paracrine and autocrine cell signaling, or applying other strategies to influence cell surface receptors and subsequent behavior. Scientists continue to evolve new approaches to pharmacologically enhancing the fracture repair process.

Citing Articles

A new osteogenic protein isolated from Thunb accelerates bone defect healing through the mTOR signaling axis.

Kubi J, Brah A, Cheung K, Lee Y, Lee K, Sze S Bioact Mater. 2023; 27:429-446.

PMID: 37152710 PMC: 10160600. DOI: 10.1016/j.bioactmat.2023.04.018.

References
1.
Storer M, Mahmud N, Karamboulas K, Borrett M, Yuzwa S, Gont A . Acquisition of a Unique Mesenchymal Precursor-like Blastema State Underlies Successful Adult Mammalian Digit Tip Regeneration. Dev Cell. 2020; 52(4):509-524.e9. DOI: 10.1016/j.devcel.2019.12.004. View

2.
Humbert P, Brennan M, Davison N, Rosset P, Trichet V, Blanchard F . Immune Modulation by Transplanted Calcium Phosphate Biomaterials and Human Mesenchymal Stromal Cells in Bone Regeneration. Front Immunol. 2019; 10:663. PMC: 6455214. DOI: 10.3389/fimmu.2019.00663. View

3.
Chen H, Cheng Q, Wang J, Zhao X, Zhu S . Long-term efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in anaemia of chronic kidney disease: A meta-analysis including 13,146 patients. J Clin Pharm Ther. 2021; 46(4):999-1009. DOI: 10.1111/jcpt.13385. View

4.
Serowoky M, Arata C, Crump J, Mariani F . Skeletal stem cells: insights into maintaining and regenerating the skeleton. Development. 2020; 147(5). PMC: 7075071. DOI: 10.1242/dev.179325. View

5.
Wan C, Gilbert S, Wang Y, Cao X, Shen X, Ramaswamy G . Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A. 2008; 105(2):686-91. PMC: 2206597. DOI: 10.1073/pnas.0708474105. View